Please use this identifier to cite or link to this item: http://148.72.244.84:8080/xmlui/handle/xmlui/4342
Title: Evaluation of Human Epidermal Growth Factor Receptor-2 in Iraqi Women with Breast Cancer
Authors: Hiba Hadi Rashid
Walaa Najm Abood
Nameer Fadhel Gaeb
Keywords: Breast cancer
serum HER2
tissue HER-2
Issue Date: يون-2019
Publisher: University of Diyala - College of Medicine
Abstract: Background:Breast cancer (BC) is the most common malignancy in Iraqi women in the recent years. There are many indicated marker for detection BC and determination the development of the tumor stage, one of the most important marker is human epidermal growth factor receptor-2 (HER2). Objective:To evaluation of serum and tissue HER2 levels among BC women and non BC women. Patients and Methods: Preoperative blood samples were collected from breast cancer women. Patients were newly diagnosing and did not receive neither radiotherapy nor chemotherapy treatment preoperatively.For the control, blood sample was collected from non-breast cancer women. All blood samples subjected to determine the serum HER-2 level. Results: A total of 52 patients with breast cancer and 30 of control were included in this study. The result showed increasing significant in serum concentration of HER-2 among BC patient compared to control and tissue her-2 positive BC patient have significantly higher serum concentration of HER-2 compared to BC patients who were tissue her-2 negative (16.23±10.37 ng/ml, 10.33±5.73 ng/ml) respectively. Conclusion: Serum HER-2 level was positively associated with tissue HER-2 level, for that is an important marker for diagnosis and monitoring BC progression.
URI: https://djm.uodiyala.edu.iq/index.php/djm
http://148.72.244.84:8080/xmlui/handle/xmlui/4342
ISSN: Print ISSN 2219-9764
Online ISSN 2617-8982
Appears in Collections:مجلة ديالى الطبية / Diyala Journal of Medicine

Files in This Item:
File Description SizeFormat 
2-Hiba Hadi Rashid.pdf334.23 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.